Etodolac
From Wikipedia, the free encyclopedia
| Image:Etodolac.png | |
| Etodolac
| |
| Systematic (IUPAC) name | |
| 1,8-diethyl-1,3,4,9-tetrahydropyrano-[3,4-b]indole-1-acetic acid | |
| Identifiers | |
| CAS number | 41340-25-4 |
| ATC code | M01AB08 |
| PubChem | 3308 |
| DrugBank | APRD00067 |
| Chemical data | |
| Formula | C17H21NO3 |
| Mol. weight | 287.354 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | 100% |
| Metabolism | ? |
| Half life | 7.3 ± 4.0 hours |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Etodolac is the International Nonproprietary Name (INN) of 1,8-diethyl-1,3,4,9-tetrahydropyrano-[3,4-b]indole-1-acetic acid (empirical formula C17H21NO3), also sold under the trade name Lodine. It is a non-steroidal anti-inflammatory drug (NSAID). It is used to treat pain associated with arthritis and other conditions.
[edit] External links
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
ǢàÒ
